EPC:NYSEEdgewell Personal Care Company Analysis
Data as of 2026-03-31 - not real-time
$21.01
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Technical snapshot: The stock trades just below its recent resistance level, with a bearish trend direction despite a bullish MACD histogram and a neutral RSI. Volume remains stable, but the 30‑day price swings are elevated, indicating heightened short‑term uncertainty.
Fundamental backdrop: Recent earnings beat expectations and a strategic divestiture of the feminine‑care segment aim to trim debt and improve cash generation. Valuation metrics such as price‑to‑book and price‑to‑sales are well below industry averages, while the forward price‑earnings multiple suggests significant upside. A modest dividend yield coupled with an exceptionally low payout ratio points to sustainable income for shareholders.
Fundamental backdrop: Recent earnings beat expectations and a strategic divestiture of the feminine‑care segment aim to trim debt and improve cash generation. Valuation metrics such as price‑to‑book and price‑to‑sales are well below industry averages, while the forward price‑earnings multiple suggests significant upside. A modest dividend yield coupled with an exceptionally low payout ratio points to sustainable income for shareholders.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- price hovering near resistance with bearish trend cues
- stable trading volume despite high volatility
- recent earnings beat reinforces short‑term confidence
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- debt‑reduction through the feminine‑care sale improves balance sheet
- forward earnings outlook yields an attractive valuation multiple
- defensive consumer‑staples positioning supports steady demand
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- low beta and defensive sector mitigate market swings
- sustainable dividend with ample payout cushion
- analyst consensus and target price upside indicate long‑run appreciation potential
Key Metrics & Analysis
Financial Health
Revenue Growth1.90%
Profit Margin-1.71%
P/E Ratio191.0
ROE0.42%
ROA3.35%
Debt/Equity104.52
P/B Ratio0.7
Op. Cash Flow$108.1M
Free Cash Flow$89.0M
Technical Analysis
TrendBearish
RSI54.3
Support$18.54
Resistance$21.80
MA 20$20.35
MA 50$20.62
MA 200$20.85
MACDBullish
VolumeStable
Fear & Greed Index74.96
Valuation
Target Price$24.33
Upside/Downside15.82%
GradeUndervalued
TypeBlend
Dividend Yield2.80%
Risk Assessment
Beta0.64
Volatility40.51%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.